Menovazan ointment, 40 g tubes
Composition
Active ingredients: 1 g of ointment contains 25 mg of racemic menthol, 10 mg of novocaine (procaine hydrochloride), and 10 mg of anesthesin (benzocaine);
Inactive ingredients: mineral oil, white soft paraffin, emulsifier T-2, purified water.
Dosage Form
Ointment.
Main physical and chemical properties: a white ointment with a menthol odor.
Pharmacotherapeutic group
Antipruritic agents. ATC code D04A X.
Pharmacological properties
Pharmacodynamics.
Menovazan is a combination drug, and its properties are determined by the action of its active ingredients. In particular, due to menthol’s selective action on cold receptors, the ointment produces a cooling sensation, and its irritating effect may be replaced by mild anesthesia. Menthol reflexively alters vascular tone. This applies to both superficial blood vessels and those located deeper. Novocaine has a fairly pronounced anesthetic effect. It does not alter vascular tone. Anesthesin induces superficial anesthesia. The combination of these components in a single preparation enables it to reversibly disrupt the excitability and conductivity of nerve receptors and conductors upon direct contact with them, exert an irritating and distracting effect, inhibit the excitation of nerve fiber membranes, reduce the amplitude of the action potential, increase the depolarization threshold of the nerve fiber membrane, slow the rate of development of the rising phase of the action potential, and reduce the degree of excitation in nerve cells.
Pharmacokinetics.
Not determined.
Indications
Neuralgia, myalgia, arthralgia; dermatoses accompanied by pruritus.
Contraindications
Hypersensitivity to any component of the drug.
Interactions with Other Medications and Other Types of Interactions
Concomitant use with other topical agents is not recommended (as it enhances the effects of drugs with local anesthetic action). The components of the drug (novocaine, anesthesin) weaken the antibacterial effect of sulfonamide drugs.
Inform your doctor if you are taking any other medications at the same time.
Special Considerations for Use
Use during pregnancy or breastfeeding. There is no experience with the use of this medication during pregnancy or breastfeeding.
Effect on reaction time when driving or operating machinery.
You should refrain from driving or operating machinery, as dizziness may occur.
Dosage and Administration
Apply topically 2–3 times daily to the painful or affected areas of the skin. The duration of treatment depends on the form and course of the disease, as well as on the nature of concomitant therapy. The maximum daily dose is 9 g.
Children
Do not use in children under 12 years of age.
Overdose
With prolonged use, dizziness, general weakness, decreased blood pressure, and allergic reactions may occur.
If such symptoms occur, discontinue use, rinse any remaining product from the skin with water, and consult a doctor. Treatment is symptomatic.
Side Effects
Allergic reactions (including redness, skin irritation, itching, rash, swelling, and hives) and contact dermatitis may occur.
Shelf Life
3 years. Do not use the product after the expiration date printed on the package.
Storage Conditions
Store at a temperature not exceeding 25 °C, out of the reach of children.
Packaging
40 g in a tube per pack.
Dispensing Category
Available without a prescription.
Manufacturer
DKP “Pharmaceutical Factory” LLC.
Similar products
Products from the same category












